Health outcomes associated with illicit prescription opioid injection:A systematic review

References

• Degenhardt L, Whiteford HA, Ferrari AJ, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet 2013; 382:1564–74.
   PubMed Web of Science ®Google Scholar
• World Drug Report 2014. Vienna: United Nations Office on Drugs and Crime, 2014.
   Google Scholar
• Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA 2000; 283(13):1710–14.
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Singh A. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008; 11(2 Suppl):S63–88.
   PubMed Web of Science ®Google Scholar
• Veilleux JC, Colvin PJ, Anderson J, York C, Heinz AJ. A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction. Clin Psychol Rev 2010; 30(2):155–66.
   PubMed Web of Science ®Google Scholar
• Fischer B, Bibby M, Bouchard M. The global diversion of pharmaceutical drugs non-medical use and diversion of psychotropic prescription drugs in North America: a review of sourcing routes and control measures. Addiction 2010; 105(12):2062–70.
   PubMed Web of Science ®Google Scholar
• Narcotic Drugs: Estimated World Requirements for 2013. New York: United Nations International Narcotics Board, 2012.
   Google Scholar
• Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 2006; 81(2):103–7.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR Morb Mortal Wkly Rep 2011; 60(43):1487–92.
   PubMedGoogle Scholar
• Bruneau J, Roy E, Arruda N, Zang G, Jutras-Aswad D. The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users. Addiction 2012; 107(7):1318–27.
   PubMed Web of Science ®Google Scholar
• Rosenblum A, Parrino M, Schnoll SH, et al. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend 2007; 90(1):64–71.
   PubMed Web of Science ®Google Scholar
• Havens JR, Walker R, Leukefeld CG. Prevalence of opioid analgesic injection among rural nonmedical opioid analgesic users. Drug Alcohol Depend 2007; 87(1):98–102.
   PubMed Web of Science ®Google Scholar
• Roxburgh A, Ritter A, Grech K, Slade T, Burns L. Trends in drug use and related harms in Australia, 2001 to 2011. Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2011.
   Google Scholar
• Guichard A, Lert F, Calderon C, et al. Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France. Addiction 2003; 98(11):1585–97.
   PubMed Web of Science ®Google Scholar
• Larance B, Ambekar A, Azim T, et al. The availability, diversion, and injection of pharmaceutical opioids in South Asia. Drug Alcohol Rev 2011; 30(3):246–54.
   PubMed Web of Science ®Google Scholar
• Marshall BD, Werb D. Health outcomes associated with methamphetamine use among young people: a systematic review. Addiction 2010; 105(6):991–1002.
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Singleton J, Calabria B, et al. Mortality among cocaine users: a systematic review of cohort studies. Drug Alcohol Depend 2011; 113(2–3):88–95.
   PubMed Web of Science ®Google Scholar
• Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev 2008; 27(3):253–62.
   PubMed Web of Science ®Google Scholar
• Darke S, Hall W, Weatherburn D, Lind B. Fluctuations in heroin purity and the incidence of fatal heroin overdose. Drug Alcohol Depend 1999; 54(2):155–61.
   PubMed Web of Science ®Google Scholar
• Frontera JA, Gradon JD. Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. Clin Inf Dis 2000; 30(2):374–9.
   PubMed Web of Science ®Google Scholar
• Roux P, Carrieri MP, Keijzer L, Dasgupta N. Reducing harm from injecting pharmaceutical tablet or capsule material by injecting drug users. Drug Alcohol Rev 2011; 30(3):287–90.
   PubMed Web of Science ®Google Scholar
• Roy E, Arruda N, Bourgois P. The growing popularity of prescription opioid injection in downtown Montreal: new challenges for harm reduction. Subst Use Misuse 2011; 46(9):1142–50.
   PubMed Web of Science ®Google Scholar
• Katz N, Dart RC, Bailey E, Trudeau J, Osgood E, Paillard F. Tampering with prescription opioids: nature and extent of the problem, health consequences, and solutions. Am J Drug Alcohol Abuse 2011; 37(4):205–17.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151(4):264–9.
   PubMed Web of Science ®Google Scholar
• Okie S. A flood of opioids, a rising tide of deaths. New Engl J Med 2010; 363(21):1981–5.
   PubMed Web of Science ®Google Scholar
• International Statistical Classifications of Diseases and Related Health Outcomes 10th Revision: World Health Organization; 2015. http://www.who.int/classifications/icd/icdonlineversions/en/ (accessed January 15, 2016).
   Google Scholar
• Downs S, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52:377–84.
   PubMed Web of Science ®Google Scholar
• Barkin RL, Barkin SJ, Barkin DS. Propoxyphene (dextropropoxyphene): a critical review of a weak opioid analgesic that should remain in antiquity. Am J Ther 2006; 13(6):534–42.
   PubMedGoogle Scholar
• Xanodyne agrees to withdraw propxyphene from the U.S. market [Internet]. U.S. Food and Drug Administration; November 19, 2010 [cited March 17, 2015].http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm234350.htm (accessed March 17, 2015).
   Google Scholar
• Darvon painkiller pulled in Canada: CBC News; 2010 [March 17, 2015]. http://www.cbc.ca/news/technology/darvon-painkiller-pulled-in-canada-1.969328 (accessed March 17, 2015).
   Google Scholar
• Hadland SE, DeBeck K, Kerr T, Feng C, Montaner JS, Wood E. Prescription opioid injection and risk of hepatitis C in relation to traditional drugs of misuse in a prospective cohort of street youth. BMJ Open 2014; 4(7):e005419.
   Web of Science ®Google Scholar
• Havens JR, Lofwall MR, Frost SD, Oser CB, Leukefeld CG, Crosby RA. Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. Am J Public Health 2013; 103(1):e44–52.
   PubMedGoogle Scholar
• Wylie JL, Shah L, Jolly AM. Demographic, risk behaviour, and personal network variables associated with prevalent hepatitis C, hepatitis B, and HIV infection in injection drug users in Winnipe Canada., BMC Public Health 2006; 6(229).
   PubMed Web of Science ®Google Scholar
• Lankenau SE, Kecojevic A, Silva K. Associations between prescription opioid injection and Hepatitis C virus among young injection drug users. Drugs (Abingdon Engl) 2015; 22(1):35–42.
   PubMedGoogle Scholar
• Zibbell JE, Hart-Malloy R, Barry JL, Fan L, Flanigan C. Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics. Am J Public Health 2014; 104(11):2226–32.
   PubMed Web of Science ®Google Scholar
• Iversen J, Wand H, Gonnermann A, Maher L. Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998–2008. Int J Drug Policy 2010; 21(6):471–6.
   PubMed Web of Science ®Google Scholar
• Ojha S, Sigdel S, Meyer-Thompson H-G, Oechsler H, Verthein U. “South Asian cocktail”—the concurrent use of opioids, benzodiazepines, and antihistamines among injecting drug users in Nepal and associations with HIV risk behaviour. Harm Reduct J 2014; 11(17). doi: 10.1186/1477-7517-11-17.
   PubMed Web of Science ®Google Scholar
• Aitken CK, Higgs PG, Hellard ME. Buprenorphine injection in Melbourne, Australia—an update. Drug Alcohol Rev 2008; 27(2):197–9.
   PubMed Web of Science ®Google Scholar
• Chelleng PK, Borkakoty BJ, Chetia M, Das HK, Mahanta J. Risk of hepatitis C infection among injection drug users in Mizoram, India. Indian J Med Res 2008; 128(5):640–6.
   PubMed Web of Science ®Google Scholar
• Das HK, Borkakoty BJ, Mahanta J, Medhi GK, Chelleng PK. Hepatitis C virus infection and risk behaviors among injection drug users of Nagaland. Indian J Gastroenterol 2007; 26(5):253–4.
   PubMedGoogle Scholar
• Mahanta J, Borkakoty B, Das HK, Chelleng PK. The risk of HIV and HCV infections among injection drug users in northeast India. AIDS Care 2009; 21(11):1420–4.
   PubMed Web of Science ®Google Scholar
• Talu A, Rajaleid K, Abel-Ollo K, et al. HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention. Int J Drug Policy 2010; 21(1):56–63.
   PubMed Web of Science ®Google Scholar
• Obadia Y, Perrin V, Feroni I, Vlahov D, Moatti J-P. Injecting misuse of buprenorphine among French drug users. Addiction 2001; 96(2):267–72.
   PubMed Web of Science ®Google Scholar
• Carrieri M-P, Rey D, Loundou A, Lepeu G, Sobel A, Obadia Y. Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users. Drug Alcohol Depend 2003; 72(1):13–21.
   PubMed Web of Science ®Google Scholar
• Kerr T, Fairbairn N, Tyndall M, et al. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend 2007; 87(1):39–45.
   PubMed Web of Science ®Google Scholar
• Pabayo R, Alcantara C, Kawachi I, Wood E, Kerr T. The role of depression and social support in non-fatal drug overdose among a cohort of injection drug users in a Canadian setting. Drug Alcohol Depend 2013; 132(3):603–9.
   PubMed Web of Science ®Google Scholar
• Havens JR, Oser CB, Knudsen HK, et al. Individual and network factors associated with non-fatal overdose among rural Appalachian drug users. Drug Alcohol Depend 2011; 115(1–2):107–12.
   PubMed Web of Science ®Google Scholar
• Silva K, Schrager SM, Kecojevic A, Lankenau SE. Factors associated with history of non-fatal overdose among young nonmedical users of prescription drugs. Drug Alcohol Depend 2013; 128(1–2):104–10.
   PubMed Web of Science ®Google Scholar
• Fischer B, Brissette S, Brochu S, et al. Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. CMAJ 2004; 171(3):235–9.
   PubMed Web of Science ®Google Scholar
• Jenkins LM, Banta-Green CJ, Maynard C, et al. Risk factors for nonfatal overdose at Seattle-area syringe exchanges. J Urban Health 2011; 88(1):118–28.
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Black E, Breen C, et al. Trends in morphine prescriptions, illicit morphine use, and associated harms among regular injecting drug users in Australia. Drug Alcohol Rev 2006; 25(5):403–12.
   PubMed Web of Science ®Google Scholar
• Ambekar A, Rao R, Mishra AK, Agrawal A. Type of opioids injected: does it matter? A multicentric cross-sectional study of people who inject drugs. Drug Alcohol Rev 2015; 34(1):97–104.
   PubMed Web of Science ®Google Scholar
• Darke S, Topp L, Ross J. The injection of methadone and benzodiazepines among Sydney injecting drug users 1996–2000: 5-year monitoring of trends from the illicit drug reporting system. Drug Alcohol Rev 2002; 21(1):27–32.
   PubMed Web of Science ®Google Scholar
• Humeniuk R, Ali R, McGregor C, Darke S. Prevalence and correlates of intravenous methadone syrup administration in Adelaide, Australia. Addiction 2003; 98:413–18.
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J, Hall W. Prevalence and correlates of the injection of methadone syrup in Sydney, Australia. Drug Alcohol Depend 1996; 43(3):191–8.
   PubMed Web of Science ®Google Scholar
• Marguery M-C, Chouini-Lalanne N, Drugeon C, et al. Hand edema and acrocyanosis: “puffy hand syndrome.” Arch Dermatol 2006; 142:1084–5.
   PubMedGoogle Scholar
• Andresz V, Marcantoni N, Binder F, et al. Puffy hand syndrome due to drug addiction: a case-control study of the pathogenesis. Addiction 2006; 101(9):1347–51.
   PubMed Web of Science ®Google Scholar
• Jenkinson RA, Clark NC, Fry CL, Dobbin M. Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue? Addiction 2005; 100(2):197–205.
   PubMed Web of Science ®Google Scholar
• Roux P, Villes V, Blanche J, et al. Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management. Drug Alcohol Depend 2008; 97(1–2):105–13.
   PubMed Web of Science ®Google Scholar
• Surratt H, Kurtz SP, Cicero TJ. Alternate routes of administration and risk for HIV among prescription opioid abusers. J Addict Dis 2011; 30(4):334–41.
   PubMed Web of Science ®Google Scholar
• Gossop M, Darke S, Griffiths P, et al. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine, and amphetamine users. Addiction 1995; 90(5):607–14.
   PubMed Web of Science ®Google Scholar
• Havens JR, Oser CB, Leukefeld CG. Injection risk behaviors among rural drug users: implications for HIV prevention. AIDS Care 2011; 23(5):638–45.
   PubMed Web of Science ®Google Scholar
• Leclerc P, Roy E, Morissette C, Michel A, Parent R, SurvUDI Working Group. Extent and correlates of injection of prescription opioids for non-medical purposes in the SurvUDI network. 20th Annual Canadian Conference on HIV/AIDS Research, 2011; Toronto, Ontario: Can. J. Infect. Dis. Med. Microbiol.
   Google Scholar
• Firestone M, Fischer B. A qualitative exploration of prescription opioid injection among street-based drug users in Toronto: behaviours, preferences, and drug availability. Harm Reduct J 2008; 5:30.
   PubMed Web of Science ®Google Scholar
• Suryaprasad AG, White JZ, Xu FJ et al. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006–2012. Clin Inf Dis 2014; 59(10):1411–9.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Community outbreak of HIV infection linked to injection drug use of oxymorphone—Indiana, 2015. Morb Mort Wkly Rep 2015; 64(16):443–4.
   PubMed Web of Science ®Google Scholar
• Lindenburg CEA, Krol A, Smit C, Buster MCA, Coutinho RA, Prins M. Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study. AIDS 2006; 20(13): 1771–1775.
   PubMed Web of Science ®Google Scholar
• Mehta SH, Astemborski J, Kirk GD, et al. Changes in blood-borne infection risk among injection drug users. J Infect Dis 2011; 203(5):587–94.
   PubMed Web of Science ®Google Scholar
• Hansen L, Penko J, Guzman D, Bangsberg DR, Miaskowski C, Kushel MB. Aberrant behaviors with prescription opioids and problem drug use history in a community-based cohort of HIV-infected individuals. J Pain Symptom Manage 2011; 42(6):893–902.
   PubMed Web of Science ®Google Scholar
• Newville H, Roley J, Sorensen JL. Prescription medication misuse among HIV-infected individuals taking antiretroviral therapy. J Subst Abuse Treat 2015; 48(1):56–61.
   PubMed Web of Science ®Google Scholar
• Anderson DT, Muto JJ. Duragesic transdermal patch: postmortem tissue distribution of fentanyl in 25 cases. J Anal Toxicol 2000; 24:627–34.
   PubMed Web of Science ®Google Scholar
• Algren DA, Monteilh CP, Punja M, et al. Fentanyl-associated fatalities among illicit drug users in Wayne County, Michigan (July 2005–May 2006). J Med Toxicol 2013; 9(1):106–15.
   PubMedGoogle Scholar
• Kronstrand R, Druid H, Holmgren P, Rajs J. A cluster of fentanyl-related deaths among drug addicts in Sweden. Forensic Sci Int 1997; 88(3):185–95.
   PubMed Web of Science ®Google Scholar
• Kuhlman Jr JJ, McCaulley R, Valouch TJ, Behonick GS. Fentanyl use, misuse, and abuse: a summary of 23 post-mortem cases. J Anal Toxicol 2003; 27: 499–504.
   Web of Science ®Google Scholar
• Stotts AL, Dodrill CL, Kosten TR. Opioid dependence treatment: options in pharmacotherapy. Expert Opin Pharmacother 2009; 10(11):1727–40.
   PubMed Web of Science ®Google Scholar
• Jones CG, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths United States,, 2010. JAMA 2013; 309(7):657–59.
   Google Scholar
• Paulozzi LJ, Ryan GW. Opioid analgesics and rates of fatal drug poisoning in the United States. Am J Prev Med 2006; 31(6):506–11.
   PubMed Web of Science ®Google Scholar
• Blanchon T, Boissonnas A, Vareseon I, Vidal-Trecan G. Homelessness and high-dosage buprenorphine misuse. Subst Use Misuse 2003; 38(3–6):429–42.
   PubMed Web of Science ®Google Scholar
• Kerr T, Small W, Hyshka E, Maher L, Shannon K. “It's more about the heroin:” injection drug users' response to an overdose warning campaign in a Canadian setting. Addiction 2013; 108(7):1270–6.
   PubMed Web of Science ®Google Scholar
• Partanen TA, Vikatmaa P, Tukiainen E, Lepantalo M, Vuola J. Outcome after injections of crushed tablets in intravenous drug abusers in the Helsinki University Central Hospital. Eur J Vasc Endovascular Surg 2009; 37(6):704–11.
   PubMed Web of Science ®Google Scholar
• Del Giudice P. Cutaneous complications of intravenous drug abuse. Br J Dermatol 2004; 150(1):1–10.
   PubMed Web of Science ®Google Scholar
• Becker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA. Non-medical use, abuse, and dependence on prescription opioids among U.S. adults: psychiatric, medical, and substance use correlates. Drug Alcohol Depend 2008; 94(1–3):38–47.
   PubMed Web of Science ®Google Scholar
• Sullivan LE, Edlund MJ, Zhang L, Unutzer J, Wells KB. Association between mental health disorders, problem drug user, and regular prescription opioid use. Arch Intern Med 2006; 166:2087–93.
   PubMed Web of Science ®Google Scholar
• Davis WR, Johnson BD. Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug Alcohol Depend 2008; 92(1–3):267–76.
   PubMed Web of Science ®Google Scholar
• Daniulaityte R, Falck RS, Wang J, Carlson RG. Illicit use of pharmaceutical opioids among young polydrug users in Ohio. Addict Behav 2009; 34(8):649–53.
   PubMed Web of Science ®Google Scholar